{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-22-001209","form_type":"8-K","ticker":"CPMV","cik":"0000836564","company_name":"Mosaic ImmunoEngineering Inc.","filed_at":"2022-02-22T23:59:59+00:00","discovered_at":"2026-05-14T18:04:09.949175+00:00","generated_at":"2026-06-27T06:23:52.519826+00:00","sec_items":["1.01","2.03","3.02","3.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Mosaic ImmunoEngineering raises $342K via 8% convertible notes with board participation","bullets":["Issued $342,632 principal of 8% convertible notes to 16 accredited investors; 5 board members invested $155,000 combined.","Proceeds of $341,632 for general purposes; notes have no maturity, 8% simple interest, convertible in future equity financing.","Conversion price: lesser of 80% of lowest per-share price in Qualified Financing (≥$5M) or $1.00; also convertible in smaller financings.","Upon corporate transaction, holders may elect 1.5x principal plus interest or conversion at $1.00 per share.","Amended May 2021 notes for certain purchasers: conversion price replaced with same formula (80% discount or $1.00)."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-22-001209","json":"https://secwatch.observer/filing/0001683168-22-001209.json","markdown":"https://secwatch.observer/filing/0001683168-22-001209.md","text":"https://secwatch.observer/filing/0001683168-22-001209.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/836564/000168316822001209/0001683168-22-001209-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/836564/000168316822001209/mosiac_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T06:23:52.519826+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}